HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer.

Abstract
Colon cancer (CC) is a leading cause of cancer mortality. Novel biomarkers are needed to identify CC patients at high risk of recurrence and those who may benefit from therapeutic intervention. The aim of this study is to investigate if miR-21 expression from RNA isolated from formalin-fixed paraffin-embedded (FFPE) tissue sections is associated with prognosis and therapeutic outcome for patients with CC. The expression of miR-21 was measured by quantitative reverse transcriptase-polymerase chain reaction in a Japanese cohort (stage I-IV, n = 156) and a German cohort (stage II, n = 145). High miR-21 expression in tumors was associated with poor survival in both the stage II/III Japanese (p = 0.0008) and stage II German (p = 0.047) cohorts. These associations were independent of other clinical covariates in multivariable models. Receipt of adjuvant chemotherapy was not beneficial in patients with high miR-21 in either cohort. In the Japanese cohort, high miR-21 expression was significantly associated with poor therapeutic outcome (p = 0.0001) and adjuvant therapy was associated with improved survival in patients with low miR-21 (p = 0.001). These results suggest that miR-21 is a promising biomarker to identify patients with poor prognosis and can be accurately measured in FFPE tissues. The expression of miR-21 may also identify patients who will benefit from adjuvant chemotherapy.
AuthorsNaohide Oue, Katsuhiro Anami, Aaron J Schetter, Markus Moehler, Hirokazu Okayama, Mohammed A Khan, Elise D Bowman, Annett Mueller, Arno Schad, Manabu Shimomura, Takao Hinoi, Kazuhiko Aoyagi, Hiroki Sasaki, Masazumi Okajima, Hideki Ohdan, Peter R Galle, Wataru Yasui, Curtis C Harris
JournalInternational journal of cancer (Int J Cancer) Vol. 134 Issue 8 Pg. 1926-34 (Apr 15 2014) ISSN: 1097-0215 [Electronic] United States
PMID24122631 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2013 UICC.
Chemical References
  • Biomarkers, Tumor
  • MIRN21 microRNA, human
  • MicroRNAs
  • Formaldehyde
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (genetics)
  • Chemotherapy, Adjuvant
  • Colonic Neoplasms (drug therapy, genetics, mortality)
  • Female
  • Formaldehyde
  • Humans
  • Male
  • MicroRNAs (biosynthesis, genetics)
  • Microsatellite Instability
  • Middle Aged
  • Neoplasm Recurrence, Local (genetics)
  • Paraffin Embedding
  • Survival
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: